# NEXT SESSION — BD Platform

**Written:** 2026-05-24 (Session 27)  
**Last commit:** `95dd91fa` (index.html — ownership model wiring)

---

## Session 27 Summary

### ✅ UCB/Candid Acquisition Backfill — Complete

Two SQL patches via Supabase REST API:

1. `companies`: Candid → `status='acquired'`, `acquired_by='ucb'`
2. `drugs` (cizutamig, cnd319, cnd460): full ownership fields set

**Ownership Propagation Audit: 15/15 checks passed**
- CND drugs render under UCB in TCell and Autoimmune tabs
- `company_id='candid'` preserved as identity anchor
- Originator pill "Candid Therapeutics" renders on each drug
- drug_area_scores (overlap=Direct) in place
- Validation: 893/893 passing

---

## Open Items — Priority Order

### 🟡 P1 — licensed_in Drug Backfill (optional, incremental)

The 12 drugs with `partnership_type='licensed_in'` or `co_developed` can be backfilled into the new ownership fields for consistency. The UCB/Candid pattern is the template:

| Drug | current_owner | originator | ownership_status |
|---|---|---|---|
| atg-201 (UCB/Antengene) | ucb | (no Antengene row) | licensed |
| SIM0709 (BI/Simcere) | boehringer | simcere | licensed |
| afimkibart (Roche/Telavant) | roche | (no Telavant row) | acquired |
| tulisokibart (Merck/Prometheus) | merck | prometheus | acquired |

Not urgent — `entity_id` still works for these. Do when convenient.

### 🟡 P2 — Company Repository UX Polish

- Area tab chips per company (which areas each company competes in)
- Sort by column header click
- BD Focus companies could show a subtle "BD" geography tag

### 🟡 P3 — Pharma Landscape Rankings → Full Supabase Drive

Keep all `pi-dr-row` editorial detail HTML intact. Replace only the summary `<tr>` data from Supabase. Not urgent until ranking data needs frequent updates.

### 🟡 P4 — Task #92 (long-pending)

Add `risk_summary` and `bd_angle` to `company_profiles` schema + backfill TL1A companies.

---

## Key Architecture State

- `current_owner_company_id` is the display routing key for acquisitions
- `company_id` is the identity anchor — never changed for any drug
- `entity_id` is preserved for legacy partnership display overrides
- Priority chain: `current_owner_company_id || entity_id || company_id`
- Future acquisitions: 2 SQL patches (company + drugs) → frontend auto-correct, no code change
- Geography `null` = BD Focus companies; `'china'`/`'global'` = ranking table companies
- `market_cap_display` (text) for "~$60B" style strings; `market_cap` (bigint) for live data

---

## Validation

893/893 ground truth tests passing.
